PMC For laboratory and research use only
It promotes cell migration to damaged tissue, supports new blood vessel formation, accelerates wound healing and has potent anti-inflammatory effects
Shaikh MS, Kale MA, Muralidharan V, Venkatachalam T, Ali SS, Islam F, et al
In the CV trial, weight loss of 5 % and 10 % was achieved by more patients receiving semaglutide 0.5 mg (36 % and 13 %) and semaglutide 1 mg (47 % and 20 %) versus patients receiving placebo 0.5 mg (18 % and 6 %) and placebo 1 mg (19 % and 7 %)
Glenmark, Celon Labs, Fresenius Cabi, Otsuka Pharma, Hetero, MSN Labs, Neon Pharma, Modi Mundi Pharma etc.
GLP-1 medications arent without risksespecially when misused or taken without medical supervision